OSN New York Retina Meeting

CME INFORMATION

Evaluations and CME Certificates

Online evaluations will be available through November 17, 2021 (please email evals@HealioLive.com if you need your login credentials). Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience: General Sessions

The intended audience for this activity is retina specialists and other health care professionals involved in the management of patients with retinal disease.

Learning Objectives: General Sessions

Upon successful completion of this activity, participants should be better able to:

  • Assess advances in vitreoretinal surgery, including the management of vitreoretinopathy, retinal detachment, scleral buckling, disruptive floaters, complications of secondary lenses, as well as the surgical management of medical diseases.
  • Examine case presentations specific to the surgical management of retinal diseases and conditions.
  • Evaluate practice patterns for diabetic eye disease, including the use of vitrectomy, pan-retinal photocoagulation, medical therapies, and telemedicine.
  • Examine case presentations specific to the care of patients with diabetic eye disease.
  • Explore the various issues that retina specialists face in managing both exudative and non-exudative age-related macular degeneration (AMD), including the management of retinal fluid, macular atrophy, the significance of drusen biogenesis, and the use of imaging to predict conversion.
  • Assess medical retina issues that are difficult to manage, including macular disease in the setting of advanced glaucoma, when to treat central serous chorioretinopathy, macular telangiectasia, and mimics of retinal disease.
  • Examine case presentations specific to the management of macular disease.
  • Summarize the latest evidence about the use of drugs and devices, including anti-VEGF therapy, biosimilars, steroids, as well as clinical studies on the treatment of geographic atrophy.
  • Describe the use of various imaging modalities, including the use of OCT biomarkers and angiography, artificial intelligence, and their place in the evaluation, diagnosis, and treatment of specific retinal conditions.
  • Examine case presentations specific to the utility of imaging in diagnostic applications.
  • Assess practice management processes and procedures that can improve patient outcomes including billing and reimbursement, optimizing workflow, and managing patients after the COVID-19 era.
  • Evaluate the latest information in pediatric retina, including inherited retinal diseases, congenital lesions, as well as diseases that appear in adulthood.
  • Examine case presentations specific to pediatric retinal diseases and conditions.
  • Examine the latest evidence, as well as case presentations pertaining to the diagnosis and management of infectious and non-infectious uveitis.

This continuing medical education activity is provided by

OSN New York Retina 2022 is supported by medical education grants from Apellis Pharmaceuticals, Inc.; Bausch + Lomb; Genentech, a member of the Roche Group.; and Regeneron Pharmaceuticals, Inc.

ACCREDITATION: Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 15.75  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to mitigate and disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.